Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Kazdal

Showing results (51-60 of 116) with videos related to

Pageof 12
Sort By:
British Journal of Cancer|August 19, 2022
Precision oncology for intrahepatic cholangiocarcinoma in clinical practiceAurelie Tomczak, Christoph Springfeld, Michael T Dill, et al.
Proteomics. Clinical Applications|December 8, 2018
Identification of MALDI Imaging Proteolytic Peptides Using LC-MS/MS-Based Biomarker Discovery Data: A Proof of ConceptRémi Longuespée, Alice Ly, Rita Casadonte, et al.
Virchows Archiv : an International Journal of Pathology|August 9, 2024
High success rate of first proficiency testing for RET fusions and RET mutations in lung and thyroid cancer samples by various methodsUdo Siebolts, Roberto Pappesch, Marcus Bauer, et al.
Lung Cancer (Amsterdam, Netherlands)|December 12, 2018
Subclonal evolution of pulmonary adenocarcinomas delineated by spatially distributed somatic mitochondrial mutationsDaniel Kazdal, Alexander Harms, Volker Endris, et al.
Der Pathologe|May 3, 2021
[Variant interpretation in molecular pathology and oncology : An introduction]Peter Horak, Jonas Leichsenring, Simon Kreutzfeldt, et al.
Nature Reviews. Clinical Oncology|August 27, 2024
Tumour mutational burden: clinical utility, challenges and emerging improvementsJan Budczies, Daniel Kazdal, Michael Menzel, et al.
Der Pathologe|October 4, 2021
Peter Horak, Jonas Leichsenring, Simon Kreutzfeldt, et al.
Genes, Chromosomes & Cancer|October 19, 2017
Targeted deep sequencing of effusion cytology samples is feasible, informs spatiotemporal tumor evolution, and has clinical and diagnostic utilityJonas Leichsenring, Anna-Lena Volckmar, Martina Kirchner, et al.
Seminars in Cancer Biology|February 25, 2021
Artificial intelligence and pathology: From principles to practice and future applications in histomorphology and molecular profilingAlbrecht Stenzinger, Maximilian Alber, Michael Allgäuer, et al.
Proteomics. Clinical Applications|July 24, 2018
Combined Immunohistochemistry after Mass Spectrometry Imaging for Superior Spatial InformationKatharina Kriegsmann, Rémi Longuespée, Michael Hundemer, et al.
Pageof 12

Showing results (51-60 of 116) with videos related to

Sort By:
Pageof 12
British Journal of Cancer|August 19, 2022
Precision oncology for intrahepatic cholangiocarcinoma in clinical practiceAurelie Tomczak, Christoph Springfeld, Michael T Dill, et al.
Proteomics. Clinical Applications|December 8, 2018
Identification of MALDI Imaging Proteolytic Peptides Using LC-MS/MS-Based Biomarker Discovery Data: A Proof of ConceptRémi Longuespée, Alice Ly, Rita Casadonte, et al.
Virchows Archiv : an International Journal of Pathology|August 9, 2024
High success rate of first proficiency testing for RET fusions and RET mutations in lung and thyroid cancer samples by various methodsUdo Siebolts, Roberto Pappesch, Marcus Bauer, et al.
Lung Cancer (Amsterdam, Netherlands)|December 12, 2018
Subclonal evolution of pulmonary adenocarcinomas delineated by spatially distributed somatic mitochondrial mutationsDaniel Kazdal, Alexander Harms, Volker Endris, et al.
Der Pathologe|May 3, 2021
[Variant interpretation in molecular pathology and oncology : An introduction]Peter Horak, Jonas Leichsenring, Simon Kreutzfeldt, et al.
Nature Reviews. Clinical Oncology|August 27, 2024
Tumour mutational burden: clinical utility, challenges and emerging improvementsJan Budczies, Daniel Kazdal, Michael Menzel, et al.
Der Pathologe|October 4, 2021
Peter Horak, Jonas Leichsenring, Simon Kreutzfeldt, et al.
Genes, Chromosomes & Cancer|October 19, 2017
Targeted deep sequencing of effusion cytology samples is feasible, informs spatiotemporal tumor evolution, and has clinical and diagnostic utilityJonas Leichsenring, Anna-Lena Volckmar, Martina Kirchner, et al.
Seminars in Cancer Biology|February 25, 2021
Artificial intelligence and pathology: From principles to practice and future applications in histomorphology and molecular profilingAlbrecht Stenzinger, Maximilian Alber, Michael Allgäuer, et al.
Proteomics. Clinical Applications|July 24, 2018
Combined Immunohistochemistry after Mass Spectrometry Imaging for Superior Spatial InformationKatharina Kriegsmann, Rémi Longuespée, Michael Hundemer, et al.
Pageof 12